{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T16:21:32Z","timestamp":1762273292833,"version":"3.40.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T00:00:00Z","timestamp":1717804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T00:00:00Z","timestamp":1717804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Model"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00894-024-05991-4","type":"journal-article","created":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T06:01:46Z","timestamp":1717826506000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Molecular modeling of multi-target analogs of huperzine A and applications in Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8019-2236","authenticated-orcid":false,"given":"Leonardo F.","family":"de Sousa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0817-2379","authenticated-orcid":false,"given":"Diego F. S.","family":"Paschoal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7281-7245","authenticated-orcid":false,"given":"Willian T. G.","family":"Novato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,8]]},"reference":[{"issue":"7","key":"5991_CR1","first-page":"1170","volume":"10","author":"L Anwal","year":"2021","unstructured":"Anwal L (2021) A comprehensive review on Alzheimer\u2019s disease. World J Pharm Pharm Sci 10(7):1170","journal-title":"World J Pharm Pharm Sci"},{"key":"5991_CR2","doi-asserted-by":"publisher","first-page":"173554","DOI":"10.1016\/j.ejphar.2020.173554","volume":"887","author":"M Vaz","year":"2020","unstructured":"Vaz M, Silvestre S (2020) Alzheimer\u2019s disease: recent treatment strategies. Eur J Pharmacol 887:173554","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"5991_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1750-3639.1991.tb00667.x","volume":"1","author":"K Beyreuther","year":"1991","unstructured":"Beyreuther K, Masters CL (1991) Amyloid precursor protein (APP) and \u0392ZA4 amyloid in the etiology of Alzheimer\u2019s disease: precursor-product relationships in the Derangement of Neuronal Function. Brain Pathol 1(4):241\u2013251","journal-title":"Brain Pathol"},{"issue":"5054","key":"5991_CR4","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA (1992) Alzheimer\u2019s disease: the amyloid Alzheimer\u2019s disease. Science 256(5054):184\u2013185","journal-title":"Science"},{"key":"5991_CR5","doi-asserted-by":"publisher","first-page":"100105","DOI":"10.1074\/jbc.REV120.008207","volume":"296","author":"P LEI","year":"2021","unstructured":"Lei P, Ayton S, Bush AI (2021) The essential elements of Alzheimer\u2019s disease. J Biol Chem 296:100105","journal-title":"J Biol Chem"},{"issue":"6","key":"5991_CR6","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med 8(6):595\u2013608","journal-title":"EMBO Mol Med"},{"issue":"23","key":"5991_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21239003","volume":"21","author":"N Zar\u0119ba","year":"2020","unstructured":"Zar\u0119ba N, Kepinska M (2020) The function of transthyretin complexes with metallothionein in Alzheimer\u2019s disease. Int J Mol Sci 21(23):1\u201316","journal-title":"Int J Mol Sci"},{"issue":"4589","key":"5991_CR8","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1126\/science.6338589","volume":"219","author":"JT Coyle","year":"1983","unstructured":"Coyle JT, Price DL, Delong MR (1983) Alzheimer\u2019s disease: a disorder of cortical cholinergic innervation. Science 219(4589):1184\u20131190","journal-title":"Science"},{"issue":"8000","key":"5991_CR9","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","volume":"2","author":"P Davies","year":"1976","unstructured":"Davies P, Maloney AJ (1976) Selective loss of central cholinergic neurons in Alzheimer\u2019s disease. Lancet 2(8000):1403","journal-title":"Lancet"},{"issue":"4","key":"5991_CR10","first-page":"267","volume":"19","author":"S KIM","year":"2011","unstructured":"Kim S, Chae Y (2011) Pain Asymbolia\u00a0: No Pain No Love. \uc2a4\ud2b8\ub808\uc2a4\u784f\u7a76 19(4):267\u2013271","journal-title":"\uc2a4\ud2b8\ub808\uc2a4\u784f\u7a76"},{"issue":"1","key":"5991_CR11","first-page":"2","volume":"6","author":"PJ Snyder","year":"2020","unstructured":"Snyder PJ et al (2020) Alzheimer\u2019s & dementia\u00a0: The Journal of the Alzheimer\u2019s Association Revisiting the cholinergic hypothesis in Alzheimer\u2019s disease\u00a0: emerging evidence from translational and clinical research. J Prev Alzheimers Dis 6(1):2\u201315","journal-title":"J Prev Alzheimers Dis"},{"issue":"5","key":"5991_CR12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0028-3908(65)90025-0","volume":"4","author":"A Pazzagli","year":"1965","unstructured":"Pazzagli A, Pepeu G (1965) Amnesic properties of scopolamine and brain acetylcholine in the rat. Neuropharmacology 4(5):291\u2013299","journal-title":"Neuropharmacology"},{"issue":"24","key":"5991_CR13","doi-asserted-by":"publisher","first-page":"115820","DOI":"10.1016\/j.bmc.2020.115820","volume":"28","author":"SX Lin","year":"2020","unstructured":"Lin SX, Curtis MA, Sperry J (2020) Pyridine alkaloids with activity in the central nervous system. Bioorg Med Chem 28(24):115820","journal-title":"Bioorg Med Chem"},{"issue":"20","key":"5991_CR14","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1016\/S0040-4020(00)00227-1","volume":"56","author":"A Haudrechy","year":"2000","unstructured":"Haudrechy A et al (2000) A formal synthesis of (+)-huperzine A. Tetrahedron 56(20):3181\u20133187","journal-title":"Tetrahedron"},{"key":"5991_CR15","doi-asserted-by":"crossref","unstructured":"Wu B, Bai D (1997) The First Total Synthesis of (\u00b1)-Huperzine B. J Org Chem 62(17):5978\u20135981","DOI":"10.1021\/jo970248f"},{"key":"5991_CR16","first-page":"113","volume":"4","author":"MKM Tun","year":"2012","unstructured":"Tun MKM, Herzon SB (2012) The pharmacology and therapeutic potential of ( - ) -huperzine A. J Exp Pharmacol 4:113\u2013123","journal-title":"Journal of Experimental Pharmacology"},{"issue":"30","key":"5991_CR17","doi-asserted-by":"publisher","first-page":"19924","DOI":"10.1021\/acsomega.1c02875","volume":"6","author":"S Anukanon","year":"2021","unstructured":"Anukanon S et al (2021) In silico-guided rational drug design and semi-synthesis of C(2)-functionalized huperzine A derivatives as acetylcholinesterase inhibitors. ACS Omega 6(30):19924\u201319939","journal-title":"ACS Omega"},{"issue":"6","key":"5991_CR18","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1039\/b409720n","volume":"21","author":"X Ma","year":"2004","unstructured":"Ma X, Gang DR (2004) The Lycopodium alkaloids. Nat Prod Rep 21(6):752\u2013772","journal-title":"Nat Prod Rep"},{"issue":"7","key":"5991_CR19","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/aps.2013.7","volume":"34","author":"JY Jia","year":"2013","unstructured":"Jia JY et al (2013) Phase I study on the pharmacokinetics and tolerance of ZT-1, a prodrug of huperzine A, for the treatment of Alzheimer\u2019s disease. Acta Pharmacol Sin 34(7):976\u2013982","journal-title":"Acta Pharmacol Sin"},{"issue":"43","key":"5991_CR20","doi-asserted-by":"publisher","first-page":"25446","DOI":"10.1039\/D0RA00722F","volume":"10","author":"DK Sigalapalli","year":"2020","unstructured":"Sigalapalli DK, Rangaswamy R, Tangellamudi ND (2020) Novel huperzine A based NMDA antagonists: insights from molecular docking. ADME\/T and molecular dynamics simulation studies. RSC Adv 10(43):25446\u201325455","journal-title":"RSC Adv"},{"key":"5991_CR21","unstructured":"Underiner G, Gibson F, He L, Supramanian H (2009) Method of preparation Huperzine A and derivatives thereof. United States Patent Application Publication. Pub. No\u00a0US2009\/0247754 A1"},{"key":"5991_CR22","unstructured":"Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman, JR, Scalmani G, Barone V, Petersson GA, Nakatsuji H, Li X, Caricato M, Marenich AV, Bloino J, Janesko BG, Gomperts R, Mennucci B, Hratchian HP, Ortiz JV, Izmaylov AF, Sonnenberg JL, Williams-Young D, Ding F, Lipparini F, Egidi F, Goings J, Peng B, Petrone A, Henderson T, Ranasinghe D, Zakrzewski VG, Gao J, Rega N, Zheng G, Liang W, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Vreven T, Throssell K, Montgomery Jr. JA, Peralta JE, Ogliaro F, Bearpark MJ, Heyd JJ, Brothers EN, Kudin KN, Staroverov VN, Keith TA, Kobayashi R, Normand J, Raghavachari K, Rendell AP, Burant JC, Iyengar SS, Tomasi J, Cossi M, Millam JM, Klene M, Adamo C, Cammi R, Ochterski JW, Martin RL, Morokuma K, Farkas O, Foresman JB, Fox, DJ (2016) Gaussian 16, Revision C.01. Gaussian, Inc., Wallingford CT"},{"issue":"7","key":"5991_CR23","doi-asserted-by":"publisher","first-page":"5648","DOI":"10.1063\/1.464913","volume":"98","author":"AD Becke","year":"1993","unstructured":"Becke AD (1993) Density-functional thermochemistry. III. The role of exact exchange. J Chem Phys 98(7):5648\u20135652","journal-title":"J Chem Phys"},{"issue":"2","key":"5991_CR24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1103\/PhysRevB.37.785","volume":"37","author":"C LEE","year":"1988","unstructured":"Lee C, Yang W, Parr RG (1988) Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys Rev B 37(2):36\u201339","journal-title":"Phys Rev B"},{"key":"5991_CR25","doi-asserted-by":"crossref","unstructured":"Ditchfield R, Hehre WJ, Pople JA (1971) Self-consistent molecular-orbital methods. IX. An extended Gaussian-type basis for molecular-orbital studies of organic molecules. J Chem Phys 54(2):724\u2013728","DOI":"10.1063\/1.1674902"},{"key":"5991_CR26","doi-asserted-by":"crossref","unstructured":"Hehre, WJ, Ditchfield R, Pople JA (1972) Self-consistent molecular orbital methods. XII. Further extensions of Gaussian-type basis sets for use in molecular orbital studies of organic molecules. J Chem Phys 56(5):2257\u20132261","DOI":"10.1063\/1.1677527"},{"key":"5991_CR27","doi-asserted-by":"crossref","unstructured":"Hariharan PC, Pople JA (1973) The influence of polarization functions on molecular orbital hydrogenation energies. Theor Chim Acta 28(3):213\u2013222","DOI":"10.1007\/BF00533485"},{"key":"5991_CR28","doi-asserted-by":"crossref","unstructured":"Rassolov VA, Pople JA, Ratner M, Windus TL (1998) 6-31G* basis set for atoms K through Zn. J Chem Phys 109(4):1223\u20131229","DOI":"10.1063\/1.476673"},{"key":"5991_CR29","doi-asserted-by":"crossref","unstructured":"Scalmani G, Frisch MJ (2010) Continuous surface charge polarizable continuum models of solvation. I. General formalism. J Chem Phys 132(11):114110","DOI":"10.1063\/1.3359469"},{"key":"5991_CR30","doi-asserted-by":"crossref","unstructured":"Pearson RG (1963) Hard and Soft Acids and Bases. J Am Chem Soc 85(22):3533\u20133539","DOI":"10.1021\/ja00905a001"},{"issue":"3","key":"5991_CR31","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","volume":"267","author":"G Jones","year":"1997","unstructured":"Jones G, Willet P, Glen RC, Leach AR, Taylor R (1997) Development and validation of a genetic algorithm for flexible docking. J Mol Biol 267(3):727\u2013748","journal-title":"J Mol Biol"},{"issue":"22","key":"5991_CR32","doi-asserted-by":"publisher","first-page":"10282","DOI":"10.1021\/jm300871x","volume":"55","author":"J Cheung","year":"2012","unstructured":"Cheung J et al (2012) Structures of human acetylcholinesterase in complex with pharmacologically important ligands. J Med Chem 55(22):10282\u201310286","journal-title":"J Med Chem"},{"key":"5991_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:1\u201313","journal-title":"Sci Rep"},{"key":"5991_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"AC Lipinski","year":"1997","unstructured":"Lipinski AC et al (1997) Experimental and computational approaches to estimate solubility and 78 permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3\u201325","journal-title":"Adv Drug Deliv Rev"},{"key":"5991_CR35","doi-asserted-by":"publisher","first-page":"64442","DOI":"10.34117\/bjdv8n9-269","volume":"8","author":"LF De Sousa","year":"2022","unstructured":"De Sousa LF, Silva LEC, Paschoal DFS, Novato WTG (2022) Study of Zinc complexes with quercetin in ethanol solution: a theoretical and experimental approach. Braz J Dev 8:64442\u201364459","journal-title":"Brazilian Journal of Development"},{"issue":"1","key":"5991_CR36","first-page":"78","volume":"43","author":"HH Fokue","year":"2020","unstructured":"Fokue HH et al (2020) Is there anything new about the molecular recognition applied to medicinal chemistry? Qu\u00edmica Nova 43(1):78\u201389","journal-title":"Qu\u00edmica Nova"},{"key":"5991_CR37","doi-asserted-by":"crossref","unstructured":"Lima VLE (1997) Drugs and chirality: a brief overview. Quim Nova 20(6):657\u2013663","DOI":"10.1590\/S0100-40421997000600015"},{"key":"5991_CR38","doi-asserted-by":"crossref","unstructured":"Mehta M, Adem A, Sabbagh M (2012) New acetylcholinesterase inhibitors for alzheimer\u2019s disease. Int J Alzheimers Dis 2012:728983","DOI":"10.1155\/2012\/728983"},{"issue":"3","key":"5991_CR39","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0304-3940(01)02437-5","volume":"317","author":"HY Zhang","year":"2002","unstructured":"Zhang HY et al (2002) Stereoselectivities of enantiomers of huperzine A in protection against \u03b2amyloid25-35-induced injury in PC12 and NG108-15 cells and cholinesterase inhibition in mice. Neurosci Lett 317(3):143\u2013146","journal-title":"Neurosci Lett"}],"container-title":["Journal of Molecular Modeling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-024-05991-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00894-024-05991-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-024-05991-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T14:48:22Z","timestamp":1720190902000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00894-024-05991-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,8]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["5991"],"URL":"https:\/\/doi.org\/10.1007\/s00894-024-05991-4","relation":{},"ISSN":["1610-2940","0948-5023"],"issn-type":[{"type":"print","value":"1610-2940"},{"type":"electronic","value":"0948-5023"}],"subject":[],"published":{"date-parts":[[2024,6,8]]},"assertion":[{"value":"16 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"200"}}